Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy

[1]  S. Lichtman,et al.  Gastrointestinal cancer in the elderly. , 1997, Clinics in geriatric medicine.

[2]  L. Norton,et al.  Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. , 1994, The New England journal of medicine.

[3]  V. Devita,et al.  Dose Intensity , 1993, Annals of the New York Academy of Sciences.

[4]  P. Newcomb,et al.  Cancer treatment and age: patient perspectives. , 1993, Journal of the National Cancer Institute.

[5]  W. Scheithauer,et al.  Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. , 1993, BMJ.

[6]  W. Panje,et al.  Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Laurie,et al.  Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. Serraino,et al.  Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  W. Hryniuk,et al.  The importance of dose intensity in chemotherapy of metastatic breast cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. Rosso,et al.  Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer. , 1998, Anticancer research.

[11]  N. Petrelli,et al.  Age and sex are independent predictors of 5‐fluorouracil toxicity. Analysis of a large scale phase III trial , 1995, Cancer.

[12]  A. Rubagotti,et al.  Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma. , 1992, European journal of cancer.

[13]  C. Erlichman,et al.  Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid. , 1992, European journal of cancer.

[14]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.